Parietaria judaica pollen

tyrosine-adsorbed glutaraldehyde-modified extract of Parietaria judaica pollen (Bencard Parietaria/Pollinex Parietaria) used as a vaccine for hyposensitization therapy; also see Pollinex-R which is a ragweed (Ambrosia) form of Pollinex

Also Known As:

Networked: 33 relevant articles (4 outcomes, 7 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Bartra, J: 2 articles (01/2013 - 07/2003)
2.	Tella, R: 2 articles (01/2013 - 07/2003)
3.	Andreu-Balaguer, Carmen: 1 article (12/2020)
4.	Anton-Girones, Mónica: 1 article (12/2020)
5.	Brugaletta, Dorimar: 1 article (12/2020)
6.	Escudero, Carmelo: 1 article (12/2020)
7.	Florido-López, José Fernando: 1 article (12/2020)
8.	Hernández, Mercedes: 1 article (12/2020)
9.	Herrero-Lifona, Leticia: 1 article (12/2020)
10.	Lara, Maria Ángeles: 1 article (12/2020)

Related Diseases

1.	Seasonal Allergic Rhinitis (Hay Fever) 11/01/1976 - "A comparative trial of hyposensitization in 1973 in the treatment of hay fever using Pollinex and Alavac-P." 10/01/2006 - "Parietaria judaica pollen is a common cause of pollinosis in the Mediterranean area. " 09/01/1981 - "[Effect of desensitization treatment with Pollinex on the T- and B-lymphocyte subpopulations in hay fever]." 01/01/1976 - "Treatment of hay fever in general practice by hyposensitization, using 'Pollinex'." 07/03/1989 - "Immunotherapy with Pollinex was performed in 46 patients with hay fever. "
2.	Asthma (Bronchial Asthma) 12/01/2020 - "AIT with Pollinex Quattro® specific for olive pollen and olive/grass pollens resulted in reduced visits to the healthcare center and emergency room and the use of asthma medication during the pollen season, indicating that this treatment was safe and effective in treating asthma in patients sensitized to these pollens." 12/01/2020 - "Of 131 study patients, 42 were treated with their usual asthma medication (control group) and 89 were treated with AIT (active group), either Pollinex Quattro® 100% olive pollen (n = 43, 48.3%) or 50% olive pollen/50% grass pollen (n = 46, 51.7%). " 03/01/1984 - "[Leukocyte migration inhibition test in patients with pollen-induced asthma and the results of hyposensitization therapy with Pollinex]." 07/01/2003 - "All had been diagnosed by clinical history and skin prick tests of allergic rhinitis and/or asthma, were monosensitised (71 to Dermatophagoides spp, 22 to Parietaria judaica pollen and 7 to grass pollen) and had been followed up as outpatients between 1990-98. " 07/09/1979 - "[Multicenter controlled trial of desensitization treatment of pollen-induced hay fever and asthma with pollinex vaccine]."
3.	Rhinitis 03/01/2003 - "Thirty patients with a well-documented clinical history of seasonal rhinitis and clinical sensitivity to Parietaria judaica pollen were included in a randomized trial during 12 months. " 09/03/1990 - "Twenty six patients with rhinitis were desensitized with Pollinex. " 10/01/2001 - "In the study group, 39 children (97%) with seasonal rhinitis and conjunctivitis treated by specific immunotherapy (Pollinex) improved. " 01/01/1976 - "Twenty-six patients from a general practice suffering with clear-cut seasonal rhinitis due to grass pollen were treated with 3 injections, at 10 to 14 day intervals, of a modified grass pollen allergens tyrosine adsorbate ('Pollinex'), prior to the 1975 pollen season. "
4.	Hypersensitivity (Allergy) 02/01/1995 - "Allergy to Parietaria judaica pollen causes significant morbidity in many areas of the world. " 02/01/1991 - "Pollinex Parietaria thus shows good potential for the control of allergy to Parietaria pollen." 09/01/1999 - "Specific immunotherapy with Parietaria judaica pollen extract has been proven to be effective in the treatment of patients with respiratory allergy induced by this pollen. " 01/01/2009 - "Recombinant hypoallergens for immunotherapy of Parietaria judaica pollen allergy." 05/01/1998 - "Efficacy and safety of oral immunotherapy in respiratory allergy to Parietaria judaica pollen. "
5.	Conjunctivitis 10/01/2001 - "In the study group, 39 children (97%) with seasonal rhinitis and conjunctivitis treated by specific immunotherapy (Pollinex) improved. " 10/01/2001 - "The aim of this study was the evaluation of efficacy of the specific immunotherapy using Pollinex for 3 years before the period of pollen dust in children with seasonal allergic rhinitis and conjunctivitis induced by grass pollen. "

Related Drugs and Biologics

1.	Glutaral (Glutaraldehyde)
2.	Tyrosine (L-Tyrosine)
3.	Vaccines
4.	aluminum sulfate (alum)
5.	Allergoids
6.	pyridine
7.	B-Lymphocyte Epitopes (B-Cell Epitope)
8.	Allergens
9.	Parietaria judaica pollen
10.	Histamine (Histamine Dihydrochloride)

Related Therapies and Procedures

1.	Immunotherapy
2.	Injections
3.	Aftercare (After-Treatment)
4.	Therapeutics